Sumalpong, Briggs Owen M.

HRN: 23-00-15  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/29/2023
MUPIROCIN 2%, 15G (TUBE)
11/29/2023
12/06/2023
TOPICAL
15g
BID
ABI
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  BloodstreamSkin & Soft TissueProphylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: